Skip to main content
Skip to navigation

All LVRNA009 articles

News
Long-term protection from SARS-CoV-2 variants in mice by a Phase II clinically evaluated original mRNA vaccine booster

2024-05-21T08:04:00Z

A new study discusses the development of an mRNA vaccine (LVRNA009) that encoded the S protein of the Wuhan-Hu-1 strain and evaluated the long-term protection potential against SARS-CoV-2 variants.